RecruitingNCT07630649
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
PHASE2 · 15 planned enrolment
- Countries listed
- 1
- Registry update
- August 5, 2026
Source-linked trial list
The registrations behind this number.
Verify the exact trial registrations behind a company, intervention, programme or topic count.
Exact trial list
2 matching trial registrations
- Intervention Ixo-vec
- Topic Vision ageing
Showing 1–2 of 2. Every record below meets all the filters shown above.
Active Not RecruitingNCT06856577
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
PHASE3 · 311 planned enrolment
- Countries listed
- 1
- Registry update
- May 22, 2026